Understanding NSCLC Treatment When You Have an EGFR Mutation
4:27
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
5:41
Understanding NSCLC Treatments for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
5:40
【HER2 inhibitors】Trastuzumab(Herceptin®), Pertuzumab, Lapatinib, Antibody-drug conjugates (KADCYLA®)
1:12:10
How Cancer Genomics is Transforming Cancer Care - Sanjay Popat
3:36
【EGFR inhibitors】Cetuximab (ERBITUX®) , Panitumumab, Erlotinib , Gefitinib (Iressa®), Afatinib
41:59
Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLC
24:29
My Stage 4 Cancer Symptoms Were DISMISSED! - Leah | Stage 4 Lung Cancer | The Patient Story
4:07